ROBERTS SYNDROME: EXAMINATION OF CHROMOSOME STABILITY
Project Number5R01HD032522-02
Contact PI/Project LeaderSCHULTZ, ROGER A.
Awardee OrganizationUT SOUTHWESTERN MEDICAL CENTER
Description
Abstract Text
DESCRIPTION (Adapted from the Investigator's Abstract): Numerical
chromosome anomalies account for a significant proportion of childhood
diseases. Much remains to be learned about cellular mechanisms responsible
for faithful chromosome segregation and maintenance of the normal genomic
constitution. One approach to the elucidation of these basic cellular
functions is through the characterization of heritable disorders exhibiting
mutant cellular phenotypes. Given that chromosome segregation is essential
for viability, few human disorders have been identified which exhibit faulty
chromosome segregation. However, one such disorder is Roberts syndrome
(RS). This rare autosomal recessive disease is clinically manifested by
mental and growth retardation, tetraphocomelia, and variable craniofacial
abnormalities. Cell lines derived from RS patients exhibit cytogenetic
abnormalities which include random chromosome loss and the premature
separation at metaphase of heterochromatic regions, a cytological phenomenon
referred to as heterochromatic repulsion (HR). RS cells also exhibit subtle
hypersensitivity to a broad spectrum of agents, including certain mutagens.
Biochemical approaches have not provided insights into RS and the disorder
is too rare for classic genetic linkage analysis. Somatic cell
hybridizations have demonstrated complementation of both the HR and
hypersensitivity phenotypes. The present application proposes to map the
gene which complements these phenotypes. RS cells will be fused with
microcells bearing few (1 to 4) chromosomes derived directly from normal
human cells. Direct human-human transfer eliminates the need to establish
the usual somatic cell hybrid intermediates used in microcell chromosome
transfer and facilitates assessment of effects rendered by simultaneous
transfer of several chromosomes. Automated genotyping will be used to
correlate complementation with a newly introduced chromosome(s). Similarly,
chromosomes transferred from cell lines bearing relevant deletions or
derivatives will facilitate finer mapping of the complementing locus. Genes
previously mapped to the area will be evaluated in a "candidate gene"
approach or, beyond the scope of this proposal, mapping data will be used
for positional cloning of the gene. Identification of a gene which corrects
RS cellular phenotypes should provide new insights into mechanisms which
influence numerical chromosome content and the avoidance of birth defects.
Eunice Kennedy Shriver National Institute of Child Health and Human Development
CFDA Code
DUNS Number
800771545
UEI
YZJ6DKPM4W63
Project Start Date
01-February-1997
Project End Date
31-January-2000
Budget Start Date
01-February-1998
Budget End Date
31-January-1999
Project Funding Information for 1998
Total Funding
$145,809
Direct Costs
$96,063
Indirect Costs
$49,746
Year
Funding IC
FY Total Cost by IC
1998
Eunice Kennedy Shriver National Institute of Child Health and Human Development
$145,809
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5R01HD032522-02
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R01HD032522-02
Patents
No Patents information available for 5R01HD032522-02
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R01HD032522-02
Clinical Studies
No Clinical Studies information available for 5R01HD032522-02
News and More
Related News Releases
No news release information available for 5R01HD032522-02
History
No Historical information available for 5R01HD032522-02
Similar Projects
No Similar Projects information available for 5R01HD032522-02